Evaluation of Nephrocerebral Risk With the Use of Cystatin C in Patients With Chronic Kidney Disease

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova - Russian Federation
doi 10.17116/jnevro201811809110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Medical News of North Caucasus
Medicine
2016English

E0670 the Potential Role of Serum Cystatin C for Renal Function Evaluation of Very Old Patients With Chronic Kidney Disease

Heart
Cardiovascular MedicineCardiology
2010English

The Use of Metformin in Patients With Chronic Kidney Disease

Annales Academiae Medicae Silesiensis
2017English

Evaluation of Periodontal Condition and Risk in Patients With Chronic Kidney Disease on Hemodialysis

Einstein (São Paulo, Brazil)
Medicine
2017English

Association Between Cystatin C and Arteriosclerosis in the Absence of Chronic Kidney Disease

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2013English

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

The Chronic Kidney Disease Epidemiology Collaboration Equation Combining Creatinine and Cystatin C Accurately Assesses Renal Function in Patients With Cirrhosis

BMC Nephrology
Nephrology
2015English

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Economic Evaluation of Egfr Control in Patients With Chronic Kidney Disease in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy